Novel antibody tests reveal complexity of immune response to covid-19
Learn More
JAX Blog
Learn about new technologies and discoveries focused on precise and personalized treatments for patients.
-
-
JAX President Edison Liu Answers Questions about the Spread of COVID-19 on Maine Calling
JAX President and CEO Edison T. Liu was the guest for the second hour of the March 31 airing of Maine Calling on Maine Public Radio.
Learn More
-
Top Tips for Overcoming the Impact of the Pandemic on Scientific Discovery
The early days of the COVID-19 pandemic created a ripple effect throughout the scientific community. Here are our top tips for staying resilient.
Learn More
-
Help for Heros | Partners on the front lines in the fight against COVID-19
Coronavirus testing at The Jackson Laboratory (JAX) helps Connecticut track and prevent transmission of COVID-19. To date, JAX has processed more than one million tests.
Learn More
-
CAR T therapy testing—how it started and how it’s going
At The Jackson Laboratory (JAX), we are working with our customers to test CAR T efficacy in solid and disseminated tumors and investigate new models of efficacy and safety testing of this nascent the
Learn More
-
Introduction: Diversity, Equity and Inclusion (DEI) blog series
The Clinical & Continuing Education team at The Jackson Laboratory is excited to announce a new Diversity, Equity & Inclusion series within our blog communications with healthcare providers. We...
Learn More
-
When should you seek clinical confirmation of consumer genomic test results?
Intro Why do millions of Americans and others around the world participate in consumer genomics? For many, testing provides a window into their innermost self, their genome, and a new way to...
Learn More
-
FAQs for Cryopreservation, Cryorecovery, and Breeding Services at JAX
Read on to find the answers to our most common questions regarding the cryopreservation, cryorecovery, and breeding services offered at JAX.
Learn More
-
Exclusively from JAX: The COVID-19 Model Portfolio
We invite you to explore our comprehensive portfolio of COVID-19 models.
Learn More
-
Shaping the Future of the Immunotherapeutic Development Pipeline
For the first time ever, drug developers have the option to accurately assess immunotoxicity and drug efficacy in the same study utilizing a novel humanized platform.
Learn More
-
Black History Month: Q&A with JAX's own
Happy Black and African American History Month from The Jackson Laboratory! According to The History Channel, Black History Month (also known as African American History Month) is an annual...
Learn More
-
Advancing Humanized NSG Mice for Immuno-Oncology Efficacy Testing
Assessing novel therapeutics that function to modulate the interaction between the human immune system and cancer cells requires advanced preclinical efficacy testing platforms. Immunologically...
Learn More
-
Five Misconceptions about Consumer Genomic Testing
Genomic testing in healthcare is here to stay. Use of testing is increasing, not only in the traditional sense (think hereditary cancer or prenatal genetics), but also outside the doctor’s...
Learn More
-
CCEP Year in Review
Intro We’ve all felt this, to the point where I hesitate to say it out of fear of sounding trite. But, 2020 has been a year like no other we’ve known in recent memory; tumultuous in so many ways....
Learn More
-
Revealing treatment options with category variants
Abstract When time isn’t on anyone’s side, how can clinicians and patients make the most educated decision for their treatment? Implementation of next-generation sequencing to uncover the...
Learn More
-
Diversity, Equity and Inclusion Blog Series
The Clinical & Continuing Education team at The Jackson Laboratory is excited to announce a new Diversity, Equity & Inclusion series within our blog communications with healthcare providers. We...
Learn More
-
Hispanic Heritage Month at JAX: Q&As with JAX’s own
Daniel Cortés-Perez Daniel Cortés-Perez Postdoctoral associate Daniel Cortés-Perez, Ph.D., conducts research in...
Learn More
-
Financial considerations of genomic tumor testing
Maria is a 70-year old woman in your practice with a new diagnosis of advanced non-small cell lung cancer (NSCLC). You plan to test a biopsy specimen for a handful of recommended genes, but what...
Learn More
-
Using RNA sequencing and other technologies to aid in variant interpretation
Malik is your 6-year-old patient with autism and global developmental delay. DNA testing did not identify a pathogenic variant (mutation) using a multi-gene neurology panel. However, a variant of...
Learn More
-
JAX Diversity Outbred Mice: A Genetically Diverse Mouse for a Diverse Human Population
Most traditional laboratory mouse strains were established by taking a mouse with unique characteristics and inbreeding it to produce a mouse population that is composed of virtually identical...
Learn More
-
Loading More...
